levofloxacin has been researched along with Adverse Drug Event in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 5 (22.73) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bloom, J; Michelassi, F; Naqvi, IA; Su, MK | 1 |
| Graf, K; Kaden, T; Li, R; Mosig, AS; Raasch, M; Rennert, K | 1 |
| Baldi, A; Sharma, A; Sharma, DK | 1 |
| Bucsa, C; Farcas, A; Huruba, M; Leucuta, DC; Mogosan, C; Sipos, M | 1 |
| Almeqdadi, M; Balakrishnan, VS; Idrees, N; Jaber, BL | 1 |
| Chawla, SPS; Chhabra, M; Gill, GK | 1 |
| Jiang, RH; Li, L; Xu, HB | 1 |
| Calhan, T; Doganay, HL; Kahraman, R; Kanat, E; Ozdil, K; Sahin, A; Senates, E; Sokmen, HM | 1 |
| Budnitz, DS; Jones, SC; Mehta, H; Sorbello, A | 1 |
| Huang, JA; Lv, XJ; Si, B; Sun, SH; Wang, C; Wu, JF; Xiao, ZK; Xie, CM; Xiu, QY; Zhang, DP; Zhang, YY; Zhao, X | 1 |
| Aguado, JM; Blanes, M; Cordero, E; Fariñas, MC; Herrero, JI; López-Ruz, MA; Martín-Dávila, P; Miguez, E; Montejo, M; Muñoz, P; Muñoz-Sanz, A; Rodrigo, J; Rosso-Fernández, CM; San-Juan, R; Silva, JT; Torre-Cisneros, J; Vidal, E | 1 |
| Beltrand, E; Blondiaux, N; Loiez, C; Migaud, H; Nguyen, S; Robineau, O; Senneville, E; Titecat, M; Valette, M | 1 |
| Aguado, JM; Torre-Cisneros, J | 1 |
| Callister, D; Ho, DY; Lutchman, G; Robilotti, E; Subramanian, A; Tien, V | 1 |
| Argentieri, A; Caroleo, MC; Cione, E; Codamo, G; De Sarro, G; Gallelli, G; Gallelli, L; Longo, P; Michniewicz, A; Siniscalchi, A; Stefanelli, R | 1 |
| Crogan-Grundy, C; Funk, J; Nguyen, DG; Presnell, SC; Robbins, JB; Roth, AB; Singer, T | 1 |
| Fukumoto, M; Hashimoto, M; Ishida, C; Kanda, Y; Kayama, T; Kunihiro, E; Okamoto, S; Yanai, T | 1 |
| Garvin, CG; Jung, R; Martin, SJ | 1 |
1 review(s) available for levofloxacin and Adverse Drug Event
| Article | Year |
|---|---|
A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Drug-Related Side Effects and Adverse Reactions; Humans; Levofloxacin; Ofloxacin; Respiratory Tract Infections; Risk Assessment; Skin Diseases, Bacterial; Urinary Tract Infections | 2001 |
3 trial(s) available for levofloxacin and Adverse Drug Event
| Article | Year |
|---|---|
Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.
Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Pilot Projects; Treatment Outcome; Turkey; Young Adult | 2013 |
A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Community-Acquired Infections; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome; Young Adult | 2014 |
Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Levofloxacin; Liver Transplantation; Male; Middle Aged; Prospective Studies; Tenosynovitis; Transplant Recipients; Treatment Outcome; Tuberculosis | 2015 |
18 other study(ies) available for levofloxacin and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Levofloxacin-associated transient mixed sensorimotor lacunar syndrome.
Topics: Brain Ischemia; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levofloxacin; Middle Aged; Stroke; Stroke, Lacunar; Tissue Plasminogen Activator | 2022 |
Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model.
Topics: Animals; Cytokines; Drug-Related Side Effects and Adverse Reactions; Endothelial Cells; Fluoroquinolones; Hepatitis; Humans; Levofloxacin | 2023 |
Levofloxacin induced bullous fixed drug eruption: a rare case report.
Topics: Adult; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Humans; Levofloxacin; Male; Quality of Life | 2022 |
A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Adverse Drug Reaction Reporting Systems; Arthralgia; Ciprofloxacin; Connective Tissue Diseases; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Musculoskeletal Diseases; Myalgia; Norfloxacin; Ofloxacin; Pain; Risk Factors; Tendinopathy; Tendons; Young Adult | 2021 |
Hemodialysis for treatment of levofloxacin-induced neurotoxicity.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levofloxacin; Neurotoxicity Syndromes; Renal Dialysis; Risk Factors | 2019 |
Levofloxacin-induced Desquamation: A Possible and Rare Case Report.
Topics: Adult; Anti-Infective Agents; Dermatitis, Exfoliative; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levofloxacin; Quality of Life | 2020 |
Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Aza Compounds; China; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Recurrence; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Drug-Related Side Effects and Adverse Reactions; Emergency Service, Hospital; Female; Fluoroquinolones; Humans; Hypersensitivity; Levofloxacin; Male; Middle Aged; Moxifloxacin; Quinolines; United States | 2013 |
Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; France; Humans; Levofloxacin; Male; Middle Aged; Prevalence; Prosthesis-Related Infections; Rifampin; Treatment Outcome; Young Adult | 2015 |
Reply to Tien et al.
Topics: Antibiotic Prophylaxis; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levofloxacin; Male; Tenosynovitis; Tuberculosis | 2015 |
Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates.
Topics: Antibiotic Prophylaxis; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Levofloxacin; Male; Tenosynovitis; Tuberculosis | 2015 |
Recognizing Severe Adverse Drug Reactions: Two Case Reports After Switching Therapies to the Same Generic Company.
Topics: Adult; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Drugs, Generic; Female; Humans; Lansoprazole; Levofloxacin; Male; Middle Aged | 2016 |
Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro.
Topics: Albumins; Bioprinting; Cell Culture Techniques; Cell Proliferation; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP3A; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Hepatocytes; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Levofloxacin; Lipopolysaccharides; Liver; Naphthyridines; Platelet Endothelial Cell Adhesion Molecule-1 | 2016 |
Post-marketing surveillance of levofloxacin 0.5% ophthalmic solution for external ocular infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Eye Infections; Eye Infections, Bacterial; Female; Humans; Infant; Infant, Newborn; Japan; Levofloxacin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Product Surveillance, Postmarketing; Treatment Outcome; Young Adult | 2012 |